Cyteir Therapeutics, Inc. (CYT): Price and Financial Metrics

Cyteir Therapeutics, Inc. (CYT): $3.02

0.07 (-2.27%)

POWR Rating

Component Grades

Momentum

C

Stability

C

Sentiment

Quality

D

Add CYT to Watchlist
Sign Up

Industry: Biotech

Industry

F

Ranked

#84 of 360

in industry

CYT Price/Volume Stats

Current price $3.02 52-week high $3.19
Prev. close $3.09 52-week low $1.48
Day low $3.00 Volume 1,006,800
Day high $3.09 Avg. volume 190,462
50-day MA $3.09 Dividend yield N/A
200-day MA $2.86 Market Cap 108.71M

CYT Stock Price Chart Interactive Chart >


Cyteir Therapeutics, Inc. (CYT) Company Bio


Cyteir Therapeutics, Inc. operates as a clinical-stage oncology company that develops novel therapeutics based on the biology of DNA repair for the treatment of cancer and synthetic lethality therapeutics for autoimmune diseases. The company engages in manufacturing therapeutics that provide precision targeting of key DNA repair factors to induce diseased cells to self-destruct by DNA damage overload and uses an integrated drug development platform that modulates the imbalance between DNA damage and repair for the therapeutic effect to deliver a pipeline of small molecule therapeutics with a range of potential disease state applications. It provides CYT-0851, an oral small-molecule inhibitor of RAD51-mediated DNA repair. It focuses on providing treatments for a range of hematological malignancies, solid tumors, and chronic autoimmune disorders. The company was incorporated in 2012 and is based in Lexington, Massachusetts.


CYT Latest News Stream


Event/Time News Detail
Loading, please wait...

CYT Latest Social Stream


Loading social stream, please wait...

View Full CYT Social Stream

CYT Price Returns

1-mo N/A
3-mo N/A
6-mo N/A
1-year -1.31%
3-year -80.54%
5-year N/A
YTD -0.66%
2023 84.24%
2022 -85.49%
2021 N/A
2020 N/A
2019 N/A

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!